Biomarker Panel for Chronic Stress Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current laboratory tests for chronic stress are inadequate as they rely on hormones like cortisol and norepinephrine, which are not suitable for general analysis and cannot discriminate between short-term and long-term stress, and have limited applications in veterinary care and ecology, as they are not relevant to many types of stressors and do not activate universal stress response pathways.

Innovation Solution

A method involving the construction of a panel of stress response biomarkers associated with multiple pathways, measured in various biological samples, to analyze persistent homeostatic perturbations, which includes selecting biomarkers such as heat shock proteins and interleukins to create a biomarker profile that reflects the type of stressor and its impact.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If hormone-based stress tests (cortisol, norepinephrine) are used, then the test can be performed in standard laboratories, but the test cannot discriminate between short-term and long-term stress and is not applicable to many stressors

Engineering Contradiction:
Improvetest implementationVSAvoidstress analysis capability
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent applies universality by developing a stress response pathway panel that can detect multiple types of stressors (physical, chemical, biological, psychological) across different organisms. The panel includes biomarkers from universal stress response pathways (heat shock proteins, interleukins, cytokines) that respond to diverse stressors, making the test applicable to humans, animals, plants, and microorganisms while maintaining laboratory feasibility through standardized measurement protocols.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Ease of operation

If hormone-based stress tests are used, then the test is simple to administer, but the test lacks precision in distinguishing chronic stress from acute stress responses

Engineering Contradiction:
Improvetest administrationVSAvoidstress differentiation accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent applies segmentation by dividing the stress response into multiple measurable components through a panel of specific biomarkers (heat shock proteins, interleukins, cytokines, hormones). Instead of relying on a single hormone measurement, the test segments the stress response across multiple pathways and molecules, allowing precise differentiation between acute and chronic stress states while maintaining operational simplicity through automated panel analysis.

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If universal stress response pathways are measured, then the test can analyze chronic stress across different organisms, but the test complexity increases due to multiple biomarkers

Engineering Contradiction:
Improvecross-organism stress analysisVSAvoidbiomarker panel complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent applies merging by combining multiple stress response biomarkers into an integrated panel that can be measured simultaneously. The panel merges measurements from heat shock proteins, interleukins, cytokines, and hormones into a unified analysis system, reducing overall complexity compared to measuring each stressor separately while maintaining the ability to detect chronic stress across different organisms.

Inventive Principle:
Principle #5Merging (Combining)

4Device complexity

If hormone-based tests are used, then the test focuses on two specific pathways (HPA axis, sympathetic nervous system), but this limits the ability to analyze molecular mechanisms of chronic stress

Engineering Contradiction:
Improvetest scopeVSAvoidmolecular mechanism data
Core Design Contradiction:
Device complexityVSLoss of information

Solution Approach 1:

The patent applies dimensionality change by expanding the test from two-dimensional (two hormone pathways) to multi-dimensional analysis. The panel incorporates multiple stress response pathways including heat shock proteins, interleukins, and cytokines alongside traditional hormones, adding molecular mechanism dimensions to the assessment while maintaining manageable test scope through systematic organization of biomarkers.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentUS10802028B2Systems and methods for analyzing persistent homeostatic perturbations
Publication Date: 2020.10.13 GAIA MEDICAL INST
  • US10802028B2 patent drawing
  • US10802028B2 patent drawing
  • US10802028B2 patent drawing

AI summary

This invention is in the field of homeostasis analysis. More particularly, it relates to systems and methods for analyzing persistent homeostatic perturbations, i.e. chronic stress, by measuring levels of biomarkers that are related to chronic stress. This invention is also directed to systems and methods for analyzing the molecular mechanisms of chronic stress.